全球3D生物列印市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計 3D 生物列印市場將從 2025 年的 36.9 億美元成長到 2034 年的 108.7 億美元，2026 年至 2034 年的複合年成長率為 12.76%。

生物技術和再生醫學的進步正在推動全球3D生物列印市場的發展。這項技術能夠利用活細胞建構複雜的生物結構，在組織工程和藥物測試領域具有巨大的應用潛力。研發投入的不斷增加正在推動創新，並拓展3D生物列印在醫療領域的應用範圍。

推動生物列印成長要素包括器官移植需求的不斷成長和供體器官的短缺。生物列印技術為人工組織和器官的開發提供了極具前景的解決方案。此外，製藥公司正在藥物研發和測試中採用這項技術，從而減少動物實驗的需求並提高效率。

未來，隨著技術的進步，市場預計將快速成長。研究機構與產業參與者之間的合作將進一步加速發展。隨著法律規範的日益完善，3D生物列印有望徹底改變個人化醫療，並重塑醫療保健的未來。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球3D生物列印市場：依技術分類

• 市場分析、洞察與預測
• 磁浮
• 噴墨法
• 注射器類型
• 雷射型
• 其他

第5章 全球3D生物列印市場：依應用分類

• 市場分析、洞察與預測
• 醫學領域
• 牙科
• 生物感測器
• 消費者/個人產品測試
• 生物墨水
• 食品和畜產品

第6章 全球3D生物列印市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • EnvisionTEC Inc
  • Organovo Holdings Inc.（now VivoSim Labs Inc.）
  • Inventia Life Science Pty Ltd
  • Poietis
  • Vivax Bio LLC
  • Allevi
  • Cyfuse Biomedical KK
  • 3D Bioprinting Solutions
  • Cellink（formerly Cellink Global）
  • Regemat 3D SL

The 3D Bioprinting Market size is expected to reach USD 10.87 Billion in 2034 from USD 3.69 Billion (2025) growing at a CAGR of 12.76% during 2026-2034.

The global 3D bioprinting market is gaining momentum due to advancements in biotechnology and regenerative medicine. This technology enables the creation of complex biological structures using living cells, offering significant potential in tissue engineering and drug testing. Increasing investments in research and development are driving innovation and expanding the applications of 3D bioprinting across healthcare sectors.

Major growth drivers include the rising demand for organ transplants and the shortage of donor organs. Bioprinting offers a promising solution by enabling the development of artificial tissues and organs. Additionally, pharmaceutical companies are adopting this technology for drug discovery and testing, reducing the need for animal trials and improving efficiency.

Looking ahead, the market is expected to experience rapid growth as technology continues to evolve. Collaboration between research institutions and industry players will further accelerate development. As regulatory frameworks become more supportive, 3D bioprinting is likely to revolutionize personalized medicine and transform the future of healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Magnetic Levitation
• Inkjet-Based
• Syringe-Based
• Laser-Based
• Others

By Application

• Medical
• Dental
• Biosensors
• Consumer / Personal Product Testing
• Bioinks
• Food and Animal Product

COMPANIES PROFILED

• EnvisionTEC Inc, Organovo Holdings Inc now VivoSim Labs Inc, Inventia Life Science Pty Ltd, Poietis, Vivax Bio LLC, Allevi, Cyfuse Biomedical KK, 3D Bioprinting Solutions, Cellink formerly Cellink Global, Regemat 3D SL
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL 3D BIOPRINTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Magnetic Levitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Inkjet-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Syringe-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Laser-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL 3D BIOPRINTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Medical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Dental Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biosensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Consumer / Personal Product Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Food and Animal Product Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL 3D BIOPRINTING MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL 3D BIOPRINTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 EnvisionTEC Inc
  • 8.2.2 Organovo Holdings Inc. (now VivoSim Labs Inc.)
  • 8.2.3 Inventia Life Science Pty Ltd
  • 8.2.4 Poietis
  • 8.2.5 Vivax Bio LLC
  • 8.2.6 Allevi
  • 8.2.7 Cyfuse Biomedical K.K
  • 8.2.8 3D Bioprinting Solutions
  • 8.2.9 Cellink (formerly Cellink Global)
  • 8.2.10 Regemat 3D S.L